Profile for Dicerna Pharmaceuticals, Inc. (DRNA)
« Back to company indexDRNA Chatter Timeline
Stock Ticker for DRNA
Most Active Tweeters for DRNA
| User | Tweets |
|---|---|
| @zerosum24 | 6 |
| @RNAiAnalyst | 6 |
| @biotrader4gain | 6 |
| @WKRBNews | 2 |
| @portefeuillefun | 2 |
Recent Tweets for DRNA
 |
@zerosum24 $DRNA knocking on that door - https://t.co/efBQzSQZwg July 19th 2017, 1:07pm |
 |
@TheMarketsDaily Dicerna Pharmaceuticals, Inc. $DRNA Lowered to “Sell” at Zacks Investment Research https://t.co/ugjWfhpy8K July 19th 2017, 1:07pm |
 |
@Optionsavvy $DRNA is looking like it may try a low range break here https://t.co/3PzX7VNEcz July 19th 2017, 8:07am |
 |
@WKRBNews Dicerna Pharmaceuticals, Inc. $DRNA Lowered to Sell at Zacks Investment Research https://t.co/6q4mw42rRq July 18th 2017, 10:07pm |
|
@WKRBNews Dicerna Pharmaceuticals, Inc. $DRNA Lowered to Sell at Zacks Investment Research https://t.co/RAhey1OkLE July 18th 2017, 10:07pm |
 |
@RatingsNetwork Dicerna Pharmaceuticals downgraded by Zacks Investment Research to sell. https://t.co/yZViDK6ulU $DRNA #DRNA July 18th 2017, 10:07pm |
 |
@AllDeltaNoTheta Sold $DRNA 3.47 centuries later July 18th 2017, 4:07pm |
 |
@biotrader4gain $DRNA needs some volume to break $3.50, tried once, maybe second attempt to break it July 18th 2017, 12:07pm |
|
@biotrader4gain RT @tgtxdough: $DRNA expects to submit a CTA in 4Q17 and initiate a Ph1 SAD/MAD trial in both HVs and PH patients in the UK and EU in early… July 18th 2017, 11:07am |
 |
@tgtxdough $DRNA expects to submit a CTA in 4Q17 and initiate a Ph1 SAD/MAD trial in both HVs and PH patients in the UK and EU in early 2018. July 18th 2017, 11:07am |
 |
@clayton_dd DRNA 3.41 Dicerna Pharmaceutic $DRNA Std Dev +2.05. DRNA Trading at 3.41 Day High 3.45 & Day Low 3.24 Change + https://t.co/GtEILf1Uam July 18th 2017, 10:07am |
|
@Optionsavvy $DRNA low range breakout is near. watching for a break of 3.5 on volume https://t.co/WS3z4Acnjx July 18th 2017, 9:07am |
 |
@RNAiAnalyst @zerosum24 why? $DRNA certainly not interested in partnering ultra-orphan hyperoxalurias. in terms of platform vali… https://t.co/t98f9YcWho July 18th 2017, 6:07am |
|
@biotrader4gain $DRNA over $3.50 could get interesting https://t.co/4U5Wm7KRBQ July 17th 2017, 9:07pm |
 |
@portefeuillefun RT @RNAiAnalyst: $DRNA file today's news under 'exceeding expectations'. Very nice work. I promise I won't tweet abt $DRNA today any more u… July 17th 2017, 8:07pm |
|
@RNAiAnalyst $DRNA file today's news under 'exceeding expectations'. Very nice work. I promise I won't tweet abt $DRNA today any more unless more news. July 17th 2017, 3:07pm |
|
@biotrader4gain $DRNA nice news this morning , setting up nicely. https://t.co/Ei8LHLz7cd July 17th 2017, 3:07pm |
|
@biotrader4gain RT @zerosum24: $DRNA breakout to watch for https://t.co/zH6LuTAtgc July 17th 2017, 2:07pm |
|
@zerosum24 $DRNA breakout to watch for https://t.co/zH6LuTAtgc July 17th 2017, 2:07pm |
|
@RNAiAnalyst What $ALNY has been up to while $DRNA found LDH to be better target than GO in primary hyperoxalurias. https://t.co/acSCrFMA7w July 17th 2017, 12:07pm |
|
@portefeuillefun RT @RNAiAnalyst: my bad: according to $DRNA presentation over weekend, PH1 represents 80% of primary hyperoxaluria cases: https://t.co/2Pd… July 17th 2017, 11:07am |
 |
@tanavoi373 RT @zerosum24: $DRNA news today makes a partnership a real possibility now before the end of the year. I would say chances just went up 60% July 17th 2017, 11:07am |
 |
@robnhoodtrader RT @zerosum24: yep $DRNA going A LOT HIGHER https://t.co/vQC50rH9JJ July 17th 2017, 11:07am |
|
@zerosum24 $DRNA news today makes a partnership a real possibility now before the end of the year. I would say chances just went up 60% July 17th 2017, 11:07am |
|
@zerosum24 yep $DRNA going A LOT HIGHER https://t.co/vQC50rH9JJ July 17th 2017, 11:07am |
 |
@Smallbios1 $DRNA this baby is worth more than $5 with today's positive development , @zerosum24 July 17th 2017, 11:07am |
 |
@Valenti88539624 RT @fascination_bio: $drna for the patient long term investor. like a new born baby in the portfolio. July 17th 2017, 11:07am |
|
@RNAiAnalyst @tanavoi373 that, plus less competitive heat from $ALNY and better target than before. $DRNA July 17th 2017, 10:07am |
|
@tanavoi373 @RNAiAnalyst maybe $DRNA gets upgrades with higher pt's tomorrow and that moves the stock. July 17th 2017, 10:07am |
 |
@fascination_bio $drna for the patient long term investor. like a new born baby in the portfolio. July 17th 2017, 10:07am |
|
@RNAiAnalyst my bad: according to $DRNA presentation over weekend, PH1 represents 80% of primary hyperoxaluria cases: https://t.co/2Pdzvu4CRL July 17th 2017, 10:07am |
|
@RNAiAnalyst $DRNA! Respect: finds gene target for ALL types of primary hyperoxaluria. Also more reliable than GO for PH1. https://t.co/igfxNv9xvT $alny July 17th 2017, 10:07am |
 |
@theLDMicro Dicerna $DRNA Expands Lead GalXC(TM) Development Program to Encompass All Forms of Primary Hyperoxaluria (PH) a... https://t.co/BkyXUMHkVz July 17th 2017, 10:07am |
 |
@Briefingcom $DRNA: Dicerna Pharmaceuticals presents new preclinical data suggesting the potential utility of DCR-PHXC for... https://t.co/QYOGvk0Lcr July 17th 2017, 9:07am |
 |
@StockNewsNow $DRNA Dicerna Expands Lead GalXC™ Development Program to Encompass All Forms of Primary Hyperoxaluria (PH) and... https://t.co/4y9jgEkkgE July 17th 2017, 8:07am |
 |
@tickerws $DRNA presents preclinical data on DCR-PHXC https://t.co/YdHQHGeOXf July 17th 2017, 7:07am |
 |
@Onellymr $DRNA Dicerna Expands Lead GalXC™ Development Program to Encompass All Forms of Primary Hyperoxaluria (... https://t.co/8Pu4QQLnmN July 17th 2017, 7:07am |
|
@biotrader4gain RT @stockboardinc: $DRNA Dicerna Expands Lead GalXC™ Development Program to Encompass All Forms of Primary Hyperoxaluria (P... - https://t.… July 17th 2017, 7:07am |
 |
@stockboardinc $DRNA Dicerna Expands Lead GalXC™ Development Program to Encompass All Forms of Primary Hyperoxaluria (P... - https://t.co/qMzxqH4Ctj July 17th 2017, 7:07am |
 |
@newswelldone $DRNA: Dicerna Expands Lead GalXC™ Development Program to …: https://t.co/mBIxb2inPw July 17th 2017, 7:07am |
 |
@WatchlistN Dicerna Pharmaceuticals $DRNA Receives Daily News Impact Rating of 0.31 https://t.co/YagCQxyrQK July 14th 2017, 3:07pm |
 |
@marketexclusive DICERNA PHARMACEUTICALS, INC. (NASDAQ:DRNA) Files An 8-K Submission of Matters to a Vote of Security Holders https://t.co/itsQ9Rl8Ly $DRNA July 12th 2017, 4:07pm |
 |
@confcalltran Submission of Matters to a Vote of Security Holders https://t.co/siTJInlxMn $DRNA July 12th 2017, 4:07pm |
 |
@popastock RT @zerosum24: $AFMD and $DRNA have similar setups.. which one will go first? Both are breakout teases, but they won't tease forever me thi… July 11th 2017, 2:07pm |
|
@zerosum24 $AFMD and $DRNA have similar setups.. which one will go first? Both are breakout teases, but they won't tease forever me thinks. July 11th 2017, 1:07pm |
 |
@emq_news Very Favorable Media Coverage Likely to Impact Dicerna Pharmaceuticals $DRNA Stock Price https://t.co/m0BKHgn7oq July 11th 2017, 9:07am |
 |
@TickerReport Very Favorable Media Coverage Likely to Impact Dicerna Pharmaceuticals $DRNA Stock Price https://t.co/YOrzfuw8Zk July 11th 2017, 9:07am |
|
@TickerReport Very Favorable Media Coverage Likely to Impact Dicerna Pharmaceuticals $DRNA Stock Price https://t.co/O58FjHNP5X July 11th 2017, 9:07am |
|
@AllDeltaNoTheta $DRNA broke through a couple MAs and positive MACD. Setting up for a breakout. July 6th 2017, 12:07pm |
|
@zerosum24 $DRNA setting up for a breakout soon - https://t.co/rhn4VBaUvR July 6th 2017, 11:07am |
Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.